BBA
ENZ

Baader Bank Aktiengesellschaft’s Enzo Biochem, Inc. ENZ Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,678
Closed -$6.63K – 533
2025
Q1 		$6.63K Buy
+22,678
New +$12.5K ﹤0.01% 408

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Baader Bank Aktiengesellschaft's ENZ Position: Q2 2025 in Review

Baader Bank Aktiengesellschaft sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 22,678 shares — an estimated $6.63K sold.

Baader Bank Aktiengesellschaft first reported a position in ENZ in Q1 2025 and held it in 1 quarter. The position peaked at $6.63K in Q1 2025. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 22,678 Enzo Biochem, Inc. shares in Q2 2025, an estimated $6.63K.
  • Baader Bank Aktiengesellschaft first reported a position in Enzo Biochem, Inc. in Q1 2025 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Enzo Biochem, Inc. position peaked at $6.63K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2025, filed 10 Jul 2025.